Global Strategy to Accelerate the Elimination of Cervical Cancer

Global Strategy to Accelerate the Elimination of Cervical Cancer is a landmark initiative spearheaded by the World Health Organization to eradicate a major cancer affecting women worldwide. Launched in November 2020, the strategy builds upon decades of scientific advancements, including the development of the HPV vaccine and high-performance screening tests. It represents the first-ever global commitment to eliminate a cancer, setting ambitious targets for 2030 to guide national and international action.

Background and Rationale

The strategy was developed in response to the persistent and inequitable burden of cervical cancer, which is almost entirely preventable yet remains a leading cause of cancer death among women in many countries. Key evidence from bodies like the International Agency for Research on Cancer and advocacy from groups including the Union for International Cancer Control highlighted the feasibility of elimination. The resolution was adopted by member states during the World Health Assembly in 2020, following extensive consultation and building on prior frameworks like the WHO Global Action Plan for the Prevention and Control of NCDs. The rationale centers on the proven tools to prevent Human papillomavirus infection and detect precancerous lesions, making elimination a tangible public health goal for the first time.

Strategic Pillars and Targets

The strategy is structured around three core pillars, each with a specific 2030 target to be met by every country. The first pillar is vaccination, aiming for 90% of girls to be fully vaccinated with the HPV vaccine by age 15. The second pillar is screening, targeting 70% of women screened with a high-performance test, such as HPV DNA testing, by ages 35 and 45. The third pillar is treatment and care, aiming for 90% of women with identified cervical disease to receive appropriate treatment, including for precancer and invasive cancer. These 90-70-90 targets, endorsed by the World Health Assembly, provide a clear and measurable roadmap for national programs.

Implementation and Key Interventions

Successful implementation requires countries to integrate cost-effective interventions into robust national health plans. Key actions include introducing or expanding HPV vaccine programs, often through partnerships with Gavi, the Vaccine Alliance for eligible nations. For screening, countries are encouraged to transition to HPV DNA testing over traditional cytology, as recommended in WHO guidelines. Treatment scale-up involves ensuring access to thermal ablation, LEEP, and timely cancer management, supported by training through institutions like the International Atomic Energy Agency. The WHO Cervical Cancer Elimination Modelling Consortium provides critical data to guide the rollout of these interventions in diverse settings, from Sub-Saharan Africa to Latin America.

Global Partnerships and Governance

The strategy is propelled by a coalition of partners under the governance of the World Health Organization. Key implementing allies include UNICEF, the World Bank, and Gavi, the Vaccine Alliance, which support vaccine procurement and health system strengthening. Civil society organizations, such as the Cervical Cancer Action Network and the George W. Bush Institute, play vital roles in advocacy and awareness. Governance is overseen by the WHO Secretariat, with progress reviewed by the World Health Assembly. Financial mechanisms, including those from the Global Fund to Fight AIDS, Tuberculosis and Malaria, are increasingly mobilized to support related health infrastructure.

Progress Monitoring and Challenges

Monitoring is facilitated by the WHO Global Cervical Cancer Elimination Dashboard, which tracks country performance against the 90-70-90 targets. Early reports show progress in vaccination coverage in countries like Australia and Rwanda, but significant gaps remain, particularly in screening and treatment access in regions like West Africa and South Asia. Major challenges include overcoming vaccine hesitancy, strengthening fragile health systems, addressing gender-related barriers to care, and securing sustainable financing. The ongoing efforts of entities like the International Papillomavirus Society and the International Cancer Control Partnership are crucial to overcoming these obstacles and maintaining momentum toward the 2030 goals.

Category:World Health Organization Category:Public health campaigns Category:Cancer